PartnerRe Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,515
| Closed | -$211K | – | 442 |
|
|
2016
Q1 | $211K | Hold |
1,515
| – | – | 0.11% | 145 |
|
|
2015
Q4 | $289K | Sell |
1,515
-2,578
| -63% | -$492K | 0.15% | 106 |
|
|
2015
Q3 | $640K | Buy |
4,093
+49
| +1% | +$7.66K | 0.11% | 134 |
|
|
2015
Q2 | $731K | Sell |
4,044
-239
| -6% | -$43.2K | 0.14% | 129 |
|
|
2015
Q1 | $742K | Buy |
4,283
+60
| +1% | +$10.4K | 0.12% | 142 |
|
|
2014
Q4 | $781K | Buy |
4,223
+602
| +17% | +$111K | 0.13% | 138 |
|
|
2014
Q3 | $600K | Sell |
3,621
-585
| -14% | -$96.9K | 0.12% | 149 |
|
|
2014
Q2 | $657K | Sell |
4,206
-575
| -12% | -$89.8K | 0.12% | 162 |
|
|
2014
Q1 | $727K | Buy |
4,781
+61
| +1% | +$9.28K | 0.12% | 158 |
|
|
2013
Q4 | $627K | Sell |
4,720
-264
| -5% | -$35.1K | 0.11% | 171 |
|
|
2013
Q3 | $579K | Sell |
4,984
-647
| -11% | -$75.2K | 0.1% | 181 |
|
|
2013
Q2 | $519K | Buy |
+5,631
| New | +$519K | 0.08% | 211 |
|